Otros idiomas Innovation1 Biotech Inc.

Acciones

IVBT

US39809D2018

Mercado cerrado - OTC Markets Otros sitios de cotización 15:31:07 19/04/2024			Varia. Cinco días.	Varia. 1 de enero.
0,0008 ^USD	-96,36 %		-.--%	-99,07 %

17/01	Innovation1 Biotech Inc. presenta los resultados del ejercicio cerrado el 31 de agosto de 2023	CI
2023	Innovation1 Biotech Inc. informa de los resultados del tercer trimestre y los nueve meses finalizados el 31 de mayo de 2023	CI

Otros idiomas

Desbloquee todas las noticias: ¡Sea el primero en enterarse y reaccione antes que los mercados!

Inscripción 100% Gratuita

Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	17/01
Innovation1 Biotech Inc. announced that it has received $0.15 million in funding	06/12
Innovation1 Biotech Inc. announced that it has received $0.02 million in funding	01/11
Innovation1 Biotech : New Financial Obligation - Form 8-K	16/10/23
Innovation1 Biotech Inc. announced that it has received $0.02 million in funding	11/10/23
Innovation1 Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	13/09/23
Innovation1 Biotech Inc. announced that it has received $0.066891 million in funding	01/09/23
Innovation1 Biotech Inc. Announces Resignation of Patrick Morris as Chairman of the Board	11/08/23
Innovation1 Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	30/05/23
Innovation1 Biotech Inc. Announces Resignation of Jeffrey Kraws as a Director	24/04/23
Innovation1 Biotech : Material Agreement - Form 8-K	24/04/23
INNOVATION1 BIOTECH INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	24/04/23
Innovation1 Biotech Inc. announced that it expects to receive $0.28 million in funding from Cavalry Fund I Management, LLC, Lincoln Park Capital, LLC, L1 Capital Pty. Limited	13/04/23
INNOVATION1 BIOTECH INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q)	17/01/23
Innovation1 Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2022	17/01/23
Innovation1 Biotech Inc. announced that it has received $0.3 million in funding from Cavalry Fund I Management, LLC, L1 Capital Pty. Limited, Lincoln Park Capital, LLC	27/12/22
Innovation1 Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2022	15/12/22
INNOVATION1 BIOTECH INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	15/12/22
Innovation1 Biotech Inc. Auditor Raises 'Going Concern' Doubt	15/12/22
INNOVATION1 BIOTECH INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	12/12/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Innovation1 Biotech Inc.

Acciones

IVBT

US39809D2018

Otros idiomas

Filtros